Benchmark’s Bill Gurley: Bubble Looms Over AI Rally
A seasoned investor at Benchmark warns that the AI boom may be inflating prices beyond fundamentals, signaling a comi...
This brief explains the asset selection logic behind equal weighted indices and how different asset classes impact portfolio balance.
23,793 articlesA seasoned investor at Benchmark warns that the AI boom may be inflating prices beyond fundamentals, signaling a comi...
A rising pushback against data centers is reshaping the debate over AI infrastructure. This article breaks down what ...
A single insider move often sparks headlines, but context matters. This article digs into what this credo insider's s...
Oklo stock popped today after a regulatory milestone signaled progress for the company’s Aurora fast-fission technolo...
Insider moves often raise questions for investors. This piece breaks down what Arteris CEO's stock sale could mean, h...
A Paychex executive recently sold a small stake, raising questions about the stock's direction. This article explains...
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
In the latest quarter, many hedge funds bought stakes in RidgePoint Heavy Equipment, a niche rental firm. The move si...
A pivotal license extension in Ghana fuels a surge in Kosmos Energy. This article breaks down what the move means for...
You don't need a big windfall to start investing for the long term. With $100, you can assemble a simple, durable Van...
Investors are buzzing after Simulations Plus announced a cash buyout at $18.50 per share. This deep-dive explains why...